XML 40 R27.htm IDEA: XBRL DOCUMENT v3.23.1
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Product Information [Line Items]      
Cash FDIC insurance $ 250,000    
Cash SIPC insurance 500,000    
Patent and licensing legal and filing fees and costs 317,340 $ 315,237  
Unrecognized tax benefits $ 0   $ 0
Cost of Sales [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk percentage 10.00% 10.00%  
General and Administrative Expense [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk percentage 26.90% 29.60%  
General and Administrative Expense [Member] | Revenue Benchmark [Member] | Product Concentration Risk [Member] | Stock Options Granted to Directors and Corporate Officers [Member]      
Product Information [Line Items]      
Concentration risk percentage 23.50% 28.40%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor One [Member]      
Product Information [Line Items]      
Concentration risk percentage 36.50% 63.80%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor Two [Member]      
Product Information [Line Items]      
Concentration risk percentage 27.60% 11.80%  
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor Three [Member]      
Product Information [Line Items]      
Concentration risk percentage 15.90%    
Research and Development Expense [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Vendor Four [Member]      
Product Information [Line Items]      
Concentration risk percentage 14.40%